Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 74.93B | 73.51B | 74.54B | 62.88B | 53.77B | 47.61B |
Gross Profit | 10.46B | 10.27B | 11.42B | 8.56B | 7.79B | 7.46B |
EBITDA | 4.82B | 3.46B | 6.00B | 4.97B | 4.71B | 3.87B |
Net Income | 221.00M | -301.00M | 1.80B | 524.00M | 600.00M | 224.00M |
Balance Sheet | ||||||
Total Assets | 66.79B | 67.78B | 67.95B | 61.64B | 56.18B | 55.74B |
Cash, Cash Equivalents and Short-Term Investments | 9.20B | 10.25B | 9.80B | 6.95B | 6.43B | 7.91B |
Total Debt | 16.64B | 17.75B | 17.59B | 17.83B | 16.71B | 17.55B |
Total Liabilities | 31.49B | 31.41B | 32.72B | 30.97B | 28.26B | 29.14B |
Stockholders Equity | 34.36B | 35.46B | 34.23B | 29.57B | 26.76B | 25.49B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 2.21B | 3.37B | -60.00M | -335.00M | 276.00M |
Operating Cash Flow | 0.00 | 5.89B | 7.11B | 2.91B | 1.87B | 3.06B |
Investing Cash Flow | 0.00 | -3.92B | -3.26B | -2.78B | -1.65B | -1.96B |
Financing Cash Flow | 0.00 | -1.90B | -1.09B | 62.00M | -1.74B | -1.34B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥9.80B | 6.85 | 5.56% | 1.02% | -5.01% | ||
73 Outperform | ¥9.67B | 4.86 | 5.55% | 1.49% | 78.77% | ||
72 Outperform | ¥10.05B | 5.56 | 3.69% | -4.87% | -19.11% | ||
63 Neutral | ¥14.75B | 234.03 | 4.43% | 2.22% | -90.98% | ||
60 Neutral | ¥10.33B | 47.19 | 5.55% | -1.39% | -116.65% | ||
56 Neutral | $3.37B | 4.05 | -1.30% | 6.64% | 0.16% | -63.79% | |
51 Neutral | ¥8.79B | ― | 3.25% | 24.16% | 93.49% |